Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Beauty Health (SKIN) Research & Development (2021 - 2025)

Beauty Health (SKIN) has disclosed Research & Development for 5 consecutive years, with $1.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Research & Development rose 53.25% to $1.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.2 million, a 36.34% decrease, with the full-year FY2024 number at $6.3 million, down 37.68% from a year prior.
  • Research & Development was $1.7 million for Q3 2025 at Beauty Health, up from $1.3 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $3.0 million in Q4 2023 to a low of $998000.0 in Q1 2025.
  • A 5-year average of $2.0 million and a median of $1.9 million in 2021 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: soared 110.65% in 2023, then plummeted 64.45% in 2025.
  • Beauty Health's Research & Development stood at $1.9 million in 2021, then dropped by 23.09% to $1.4 million in 2022, then skyrocketed by 110.65% to $3.0 million in 2023, then plummeted by 59.88% to $1.2 million in 2024, then surged by 38.95% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Research & Development are $1.7 million (Q3 2025), $1.3 million (Q2 2025), and $998000.0 (Q1 2025).